Paul Kirkham
Researcher
Faculty of Medicine
National Heart Lung Institute
United Kingdom
Biography
Paul Kirkham is a Royal Society Fellow and Honorary Senior Lecturer who has recently made the transition from industrial pharma research at Novartis back into academia. He has over 11 years experience in respiratory disease research, preceded by 8 years in cellular immunology. He is an established investigator and has published papers on oxidative stress and its impact on the pathogenesis of respiratory disease, in particular COPD. Whilst in pharma he led research projects into therapeutic approaches to overcome steroid insensitivity in COPD and severe asthma. The main focus of his research involves investigating the role of oxidative and carbonyl stress on cell function and inflammation in chronic respiratory diseases, such as COPD and severe asthma. He is ultilising a multidisciplinary approach drawing on molecular, pharmacological and proteomic techniques, in order to translate clinical observations into mechanisms of disease pathogenesis. He is currently focussing on the role of carbonyl stress in triggering autoimmune reponses and the pathological damage that ensues within the lungs of COPD patients.
Research Interest
Inflammation, Immunology
Publications
-
Kirkham PA, Caramori G, Casolari P, et al., 2011, Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, Vol:184, ISSN:1073-449X, Pages:796-802
-
Ngkelo A, Meja K, Yeadon M, et al., 2012, LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and G(i)alpha dependent PI-3kinase signalling, Journal of Inflammation-london, Vol:9, ISSN:1476-9255, Pages:1-1